Navigation path

Pharmaceuticals - Union Register


List of refusals for human medicinal products

Sumatriptan Galpharm

Product name: Sumatriptan Galpharm
Active substance: sumatriptan
Indication: Acute relief of migraine attacks, with or without aura.
Sumatriptan Galpharm should only be used where there is a clear diagnosis of migraine
Marketing Authorisation Holder: Galpharm Healthcare Ltd

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/02/2012 Centralised - Refusal of marketing authorisation EMEA/H/C/2140 (2012)895 of 9/02/2012